Mink Therapeutics
Price & Volume
Stats
See more52W Range | $4.56-$19 |
Market Cap | $40.3M |
Shares Short | 150,671 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.70 |
News
See moreYahoo Finance • 10 hours ago
MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
Yahoo Finance • 20 days ago
MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
Yahoo Finance • last year
MiNK Therapeutics Reports Third Quarter 2023 Results
About
CEO | Dr. Jennifer S. Buell Ph.D. |
Address | 149 Fifth Avenue, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 31 |
